Omnimmune Holdings, Inc.
OMMH · OTC
12/31/2009 | 12/31/2008 | 5/31/2008 | 5/31/2007 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | -0.00 | 0.00 |
| FCF Yield | -28,542.28% | -317,681.29% | -22,133.58% | 7,043.81% |
| EV / EBITDA | -1.49 | -0.40 | -19.97 | 8.58 |
| Quality | ||||
| ROIC | 0.00% | 368.13% | 0.00% | 0.00% |
| Gross Margin | 0.00% | 0.00% | 100.00% | 0.00% |
| Cash Conversion Ratio | 0.14 | 0.32 | 1.49 | -8.70 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | – | 76,246.07% | -100.00% |
| Free Cash Flow Growth | 86.79% | -2,595.74% | -195.73% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -1.49 | -0.40 | -19.96 | 8.70 |
| Interest Coverage | -6.36 | -0.78 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |